Oestrogen receptor polymorphisms in female patients with rheumatoid arthritis

Scandinavian Journal of Rheumatology

Volumn 40, Issue 5, 2011, Pages 329-333

  Dziedziejko, V ^a   Kurzawski, M ^a   Safranow, K ^a   Drozdzik, M ^a   Chlubek, D ^a   Pawlik, A ^a,b  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b Department of Pharmacokinetics and Therapeutic Drug Monitoring ^*  (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; ESTROGEN RECEPTOR; GLUCOCORTICOID; METHOTREXATE; RHEUMATOID FACTOR;

ADULT; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC REGULATION; GENOTYPE; HETEROZYGOTE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE OF ONSET; AGED; ARTHRITIS, RHEUMATOID; ESTROGEN RECEPTOR ALPHA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 80053387794     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2011.563752     Document Type: Article

References (35)

1. Klareskog L, Catrina AI, Paget S. Rheumatoid arthritis. Lancet 2009;373:659-72.
2. Silman AJ, Pearson JE. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res 2002;4(Suppl 3):S265-72.
3. Paradowska-Gorycka A, Grzybowska-Kowalczyk A, Wojtecka- Lukasik E, Maslinski S. IL-23 in the pathogenesis of rheumatoid arthritis. Scand J Immunol 2010;71:134-45.
4. Lundy SK, Sarkar S, Tesmer LA, Fox DA. Cells of the synovium in rheumatoid arthritis. T lymphocytes. Arthritis Res Ther 2007;9:202.
5. Kinne RW, Brauer R, Stuhlmuller B, Palombo-Kinne E, Burmester GR. Macrophages in rheumatoid arthritis. Arthritis Res 2000;2:189-202. (Pubitemid 32223726)
6. Chang JS, Quinn JM, Demaziere A, Bulstrode CJ, Francis MJ, Duthie RB, et al. Bone resorption by cells isolated from rheumatoid synovium. Ann Rheum Dis 1992;51:1223-9.
7. Laivoranta-Nyman S, Luukkainen R, Hakala M, Hannonen P, Mottonen T, Yli-Kerttula U, et al. Differences between female and male patients with familial rheumatoid arthritis. Ann Rheum Dis 2001;60:413-5. (Pubitemid 32242759)
8. Cutolo M, Villaggio B, Craviotto C, Pizzorni C, Seriolo B, Sulli A. Sex hormones and rheumatoid arthritis. Autoimmunity Rev 2002;1:284-9. (Pubitemid 38352571)
9. Capellino S, Montagna P, Villaggio B, Soldano S, Straub RH, Cutolo M. Hydroxylated estrogen metabolites influence the proliferation of cultured human monocytes: possible role in synovial tissue hyperplasia. Clin Exp Rheumatol 2008;26:903-9.
10. Kramer PR, Kramer SF, Guan G. 17 beta-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages. Arthritis Rheum 2004;50:1967-75. (Pubitemid 38725109)
11. Cutolo M, Capellino S, Montagna P, Ghiorzo P, Sulli A, Villaggio B. Sex hormone modulation of cell growth and apoptosis of the human monocytic/macrophage cell line. Arthritis Res Ther 2005;7:R1124-32.
12. Julkunen H. Hormone replacement therapy in women with rheumatic diseases. Scand J Rheumatol 2000;29:146-53. (Pubitemid 32014426)
13. Rovensky J, Kvetnansky R, Radikova Z, Imrich R, Greguska O, Vigas M, et al. Hormone concentrations in synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 2005;23:292-6. (Pubitemid 40823535)
14. Cutolo M, Sulli A, Capellino S, Villaggio B, Montagna P, Seriolo B, et al. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 2004;13:635-8. (Pubitemid 39279773)
15. Ushiyama T, Inoue K, Nishioka J. Expression of estrogen receptor related protein (p29) and estradiol binding in human arthritic synovium. J Rheumatol 1995;22:421-6.
16. Khalkhali-Ellis Z, Seftor EA, Nieva DR, Handa RJ, Price RH Jr, Kirschmann DA, et al. Estrogen and progesterone regulation of human fibroblast-like synoviocyte function in vitro: implications in rheumatoid arthritis. J Rheumatol 2000;27:1622-31. (Pubitemid 30462802)
17. Cutolo M, Accardo S, Villaggio B, Clerico P, Bagnasco M, Coviello DA, et al. Presence of estrogen-binding sites on macrophage- like synoviocytes and CD8+, CD29+, CD45RO+ T lymphocytes in normal and rheumatoid synovium. Arthritis Rheum 1993;36:1087-97. (Pubitemid 23229285)
18. Cutolo M, Sulli A, Barone A, Seriolo B, Accardo S. Macrophages, synovial tissue and rheumatoid arthritis. Clin Exp Rheumatol 1993;11:331-9. (Pubitemid 23236139)
19. Shupnik MA, Pitt LK, Soh AY, Anderson A, Lopes MB, Laws ER Jr. Selective expression of estrogen receptor alpha and beta isoforms in human pituitary tumors. J Clin Endocrinol Metab 1998;83:3965-72. (Pubitemid 28513580)
20. Menasce LP, White GR, Harrison CJ, Boyle JM. Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. Genomics 1993;17:263-5. (Pubitemid 23205095)
21. Boot AM, van der Sluis IM, de Muinck Keizer-Schrama SM, van Meurs JB, Krenning EP, Pols HA, et al. Estrogen receptor alpha gene polymorphisms and bone mineral density in healthy children and young adults. Calcif Tissue Int 2004;74:495-500. (Pubitemid 38780284)
22. Silvestri S, Thomsen AB, Gozzini A, Bagger Y, Christiansen C, Brandi ML. Estrogen receptor alpha and beta polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy? Menopause 2006;13:451-61.
23. Ugai K, Nishimura K, Fukino K, Nakamura T, Ueno K. Functional analysis of transcriptional activity of cytosine and adenine (CA) repeats polymorphism in the estrogen receptor beta gene. J Toxicol Sci 2008;33:237-40. (Pubitemid 351872365)
24. Kim JJ, Choi YM, Choung SH, Yoon SH, Lee GH, Moon SY. Estrogen receptor beta gene +1730 G/A polymorphism in women with polycystic ovary syndrome. Fertil Steril 2010;93:1942-7.
25. Ashton KA, Proietto A, Otton G, Symonds I, McEvoy M, Attia J, et al. Estrogen receptor polymorphisms and the risk of endometrial cancer. BJOG 2009;116:1053-61.
26. Ushiyama T, Mori K, Inoue K, Huang J, Nishioka J, Hukuda S. Association of oestrogen receptor gene polymorphisms with age at onset of rheumatoid arthritis. Ann Rheum Dis 1999;58:7-10. (Pubitemid 29112943)
27. Takagi H, Ishiguro N, Iwata H, Kanamono T. Genetic association between rheumatoid arthritis and estrogen receptor microsatellite polymorphism. J Rheumatol 2000;27:1638-42. (Pubitemid 30462804)
28. Karlson EW, Chibnik LB, McGrath M, Chang SC, Keenan BT, Costenbader KH, et al. A prospective study of androgen levels, hormone-related genes and risk of rheumatoid arthritis. Arthritis Res Ther 2009;11:R97.
29. Schuit SC, de Jong FH, Stolk L, Koek WN, van Meurs JB, Schoofs MW, et al. Estrogen receptor alpha gene polymorphisms are associated with estradiol levels in postmenopausal women. Eur J Endocrinol 2005;153:327-34. (Pubitemid 41167491)
30. Kok HS, Onland-Moret NC, van Asselt KM, van Gils CH, van der Schouw YT, Grobbee DE, et al. No association of estrogen receptor alpha and cytochrome P450c17alpha polymorphisms with age at menopause in a Dutch cohort. Hum Reprod 2005;20:536-42. (Pubitemid 40277629)
31. Tsokos GC, Kammer GM. Molecular aberrations in human systemic lupus erythematosus. Mol Med Today 2000;6:418-24.
32. Salem ML. Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production. Curr Drug Targets Inflamm Allergy 2004;3:97-104. (Pubitemid 38854894)
33. Straub RH. The complex role of estrogens in inflammation. Endocr Rev 2007;28:521-74. (Pubitemid 47236336)
34. van Vollenhoven RF, Houbiers JG, Buttgereit F, In 't Hout J, Boers M, Leij S, et al. The selective estrogen receptor alpha agonist Org 37663 induces estrogenic effects but lacks antirheumatic activity: a phase IIa trial investigating efficacy and safety of Org 37663 in postmenopausal female rheumatoid arthritis patients receiving stable background methotrexate or sulfasalazine. Arthritis Rheum 2010;62:351-8.
35. Roman-Blas JA, Castañeda S, Cutolo M, Herrero-Beaumont G. Efficacy and safety of a selective estrogen receptor β agonist, ERB-041, in patients with rheumatoid arthritis: a 12-week, randomized, placebo-controlled, phase II study. Arthritis Care Res (Hoboken) 2010;62:1588-93.